Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35 (2013), Issue 5, Pages 317–325
http://dx.doi.org/10.1155/2013/935943
Research Article

Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma

Department of Cellular & Molecular Biology, Beijing TB and Thoracic Tumor Research Institution/Beijing Chest Hospital, Capital Medical University, 97 Beimachang, Tongzhou, Beijing 101149, China

Received 15 June 2013; Revised 20 August 2013; Accepted 21 August 2013

Academic Editor: Sun-Il Hwang

Copyright © 2013 Li Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Li Ma, Wentao Yue, Yu Teng, Lina Zhang, Meng Gu, and Yue Wang, “Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma,” Disease Markers, vol. 35, no. 5, Article ID 935943, 9 pages, 2013. doi:10.1155/2013/935943